We have also obtained preliminary evidence for similar enrichment of Annexin-V+ events among CD4+ T cells reactive with TAA (but not FluM1) tetramer probes in HLA-DR4+ patients with RCC (Figure 7). Here, ANXA5 is linked to renal cell carcinoma.